The New Treatment Innovation Grant supports Australian researchers in developing early-stage, innovative ideas to improve pancreatic cancer treatments, diagnostics, and care quality, with a focus on generating preliminary data, answering key feasibility questions, and accelerating research translation.

The New treatment Innovation Grant will provide funding to Australian researchers to:

• Carry out projects at an early stage that will accelerate innovation of treatments, diagnostics or quality (including standard of care) to pancreatic cancer patients
• Support innovative ideas that have the potential to impact treatment or diagnostics, but may not have extensive preliminary supporting data
• Answer key feasibility and proof-of-concept questions and arrive at critical project inflection points in an accelerated time frame
• Support established and/or early career researchers to develop preliminary data and attract additional funding in subsequent years
• Accelerate research translation

Criteria for funding

• Applications should demonstrate solid rationale and extensive planning
• Proof-of-concept or exploratory data to demonstrate the feasibility and rationale for your research questions should be detailed sufficiently
• Applicants must disclose any potential overlap with other current or pending research funding
• Where applications have multiple AI's, the role of each co-investigator must be outlined and justified
• Only one application per institution may be submitted for each scheme
• International collaborations are encouraged if the PI is located in Australia

• Phone: (02) 7207 6970
• Email: info@pankind.org.au